Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
THE USE OF DIALYZABLE BOVINE COLOSTRUM EXTRACT IN CONJUNCTION WITH A HOLISTIC TREATMENT MODEL FOR NATURAL KILLER CELL STIMULATION IN CHRONIC ILLNESS Solstice Clinical Associates, Tucson, Arizona, July, 1998 Abstract A longitudinal evaluation of the natural killer cell (NK activity) of peripheral blood lymphocytes was performed in 107 patients with documented and advanced Chronic Illness and followed for an average period of 13.2 months. At the time of primary evaluation and treatment, the absolute value of natural killer cell activity was significantly lower than the normal range. Hence, the association of chronic illness with the syndrome of low natural killer cell activity. During the follow-up period, a variety of nutritional agents were given to support natural killer cell function and then dialyzable bovine colostrum extract was added to the protocol. In the ensuing months, the curve of NK cell reactivation into normal ranges and above was monitored as immune system competence was restored. The use of natural immunomodulators including the use of dialyzable bovine colostrum extract can be concluded as a viable therapeuticum in NK cell reactivation in the face of Chronic Illness. Clinical Study Summary and Discussion The participants: Charts of 107 patients who presented with chronic illness which were known to include low NK cell function were studied to determine their NK cell function response after being treated with a complimentary medical regimen of therapy. This regimen included the use of dialyzable bovine colostrum/whey extracts as well as other elements of the Holistic Medical Paradigm. The patients all self-selected this medical approach and most came with specific expectations having read (1) Chronic Fatigue Syndrome: The Hidden Epidemic or, (2) The Definitive Guide to Cancer Therapy. An overview of the immune system: The marvelous array of deftly interacting cells that defend our invaders arise from a few precursor cells that first appear at about conception. From that point on, the cells of the immune system continuously repeated cycle of growth and development and competent at around 6 months of age after our birth. body against 9 weeks after go through a become fully The parent cells of our immune system are referred to as stem cells. These are the cells upon which the immune system depends to both reproduce itself and gives rise to the many specialized lineage's that spring from it; the B cells, macrophages, natural killer (NK) cells, helper T cells, etc. The cells of the immune system are not isolated in a single body space or arranged in the form of a single organ. Instead, the majority of them exist as potentially mobile entities unattached to other cells. This characteristic is crucial to their function. Every minute of every day, war is waged within our body. The combatants are too small to see. Some, like the infamous HIV virus, are so small that 230 million would fit on the period at the end of this sentence. Yet, they employ tactics that can vanquish the much larger cells upon which our immune system is based. Usually, we never even notice the battles within us. We have evolved legions of defenders, specialized cells that silently destroy the unseen enemy. Sometimes these warriors mistake harmless invaders such as pollen for deadly foes and trigger an allergic response. Occasionally, some of our own cells begin the mutinous uncontrolled proliferation characteristic of cancer and manage to evade the surveillance of our body's defensive forces. For every successful penetration of our defenses, millions of attempts are repelled. We sleep securely at night trusting the invisible vigilantes of our immune system. The science and practice of immunology traces back to 1721 to Lady Mary Wortley Montagu. She introduced England to a Turkish process of inoculation with unmodified smallpox virus in an attempt to stem the ravages of the normal course of the disease. Her techniques were quite crude and as many as her patients died as survived but those that survived were immune to the disease forever more. Over the decades and centuries scores of doctors and researchers honed the art of immunology into a more and more refined science. Many of the wonderful blood tests that we have today and information that we now know about immunology was unknown to us a scant 20 years ago. Information on the science of immunology doubles at the rate of approximately every 5 to 6 years. So we must remember that the wonderful ways that we have today to support and direct the immune system to help protect us and fight off illnesses is a mere foreshadow of things to come in the (near) future Our immune system is a miracle of evolution. There is interesting research to suggest that elements of our immune system were, at one time, actually independent organisms. They were incorporated into our body millions and millions of years ago as a type of symbiotic mutually beneficial relationship. Our immune system is not controlled by any central organ such as the relationship of our brain to our nervous system. Rather it has developed and functions as a kind of biological democracy where the individual members achieve their ends through an information network of biochemical substances called cytokines. Many different variables in our environment and lifestyle can effect the efficiency of its function. Our immune system accounts for approximately 1% of our body's 100 trillion cells. These defender cells originally arise in our bone marrow and mature in other parts of our body, the thymus, spleen and lymph glands. The different lineage's which develop all share one common objective; to identify and destroy all substances, living or inert, that are recognized as foreign to our body. This includes cancer cells that challenge our immune system everyday for each and every one of us. NK Cells: NK cells were discovered in the 1970's and constitute up to 15% of the total lymphocyte population in normal healthy subjects. They are capable of killing a broad range of tumor and virus infected cells. Depressed NK cell activity and depressed NK cell populations are associated with the development and rapid progression of cancer, hepatitis, AIDS, Chronic Fatigue Syndrome, various immunodeficiency syndromes, and certain autoimmune diseases. In my practice I almost exclusively work with people with severe and chronic diseases, diseases that are known to present abnormally low levels of NK cell function. NK cells now appear to present the first line of defense against metastatic spread of tumors. In numerous studies, low NK cell populations were correlated with greater and more rapid spread of tumors with shorter host longevity and with greater morbidity. The immune response: There are four critical phases to the immunological response and lifestyle issues and some dietary supplements can influence them. During phase one, the offending invader is identified and recognized as being foreign to our body and then quickly consumed by hungry roving macrophages. You can think of macrophages as little PAC men that are found in all of the tissues in our body and circulating around in our blood stream looking for their next free lunch. They seize upon this foreign agent, engulf it, eat it and release a series of cytokines that then trigger the 2nd phase of the immunological reaction. In phase two, these biochemical substances then activate the helper T cells that have the job of coordinating the counterattack on a body-wide scale. The T cells then begin to multiply and release other cytokines that further stimulate more T cells, B cells, and natural killer cells. As the number of B cells increase, the helper T cells signal them to begin producing antibodies, thus, bringing us to the 3rd stage of the immunological response. In the third stage, the antibodies are circulating around in our blood stream and are attaching to the foreign virus or bacteria causing them to be more quickly engulfed by macrophages or killed by natural killer cells. The fourth stage of the immunological response begins when the circulating antibodies no longer have a target and the suppresser T cells call a truce to the immunological reaction bringing about a new balance, or homeostasis, in our system. Special cells of the immune system remember what had transpired so that if again attacked by the same organism our body could respond much faster. These cells also release special little molecules called transfer factor to help keep the pump primed, so to speak. Thus, what may have been a 10-day bout from our first exposure to that particular virus, in the future may be a cold that lasts no more than 24-72 hours. Immune-modulation: Immune-modulation is a new and key step in supporting immune function. This can include a number of different substances, depending upon the situation, including: transfer factor (obtained in specially prepared colostrum/whey extracts), Astragalus, Arabinogalactan, Viscum extracts, vitamin C, iodine, lactoferrin, certain amino acids, neurotransmitter hormones and the prohormone DHEA. Transfer Factor: In the study group generic NK cell response was monitored using transfer factor, obtained in specially prepared colostrum/whey extracts, along with the herb Astragalus that is known to accelerate and support immunological reactions. The transfer factor component was produced from cows that have been immunologically stimulated using a patented process. This process does not hurt the cow. In fact, it stimulates the cow’s immune system for its own protection. When a cow gives birth to a calf, the first flow of milk is called the colostrum. The colostrum is collected and the transfer factor molecules are extracted. At appropriate opportunities, collection can also occur from the milk following colostrum. This is generally referred to as whey. Since none of the milk proteins remain, these products are safe even for people with a dairy allergy. The purified transfer factor can then be given to people to passively stimulate their NK cells function to alert-activity status, thus protecting them to a significant degree from illness as well as helping them recover from illness. Lifestyle: Lifestyle issues that will affect the functioning of our immune system include exposure to toxins (heavy metals, petrochemicals, radiation, etc.) and dietary and nutritional deficiencies that can rob the immune system of the biochemical foundation that it relies upon in order to function normally. Another major lifestyle issue relative to immune function is stress. Dietary supplements used by the Study Group: The use of other nutritional support factors in conjunction with the dialyzable colostrum/whey extract and astragalus was important for patient recovery. However, I want to point out three significant factors in relation to that fact: 1. Most of the patients were advanced in their conditions and had tried other approaches for their health recovery before I saw them in my clinic. 2. The dialyzable colostrum/whey extract was critical to their recovery. Without that component, providing the transfer factors discussed herein, many of the patients simply would not have recovered. 3. I have utilized a wide array of well-known and privately prepared colostrum products with disappointing results. These products were not helpful to my patients as they failed to significantly increase NK cell function or consistently provide any other significant immunological benefits that could be measured. I also observed that people who were not severely compromised responded well to daily supplementation of the colostrum/whey extract and astragalus without additional nutritional supplementation. Even though adequate nutritional support is important it was noted that the extract of dialyzable colostrum/whey and astragalus is very powerful and valuable in combination without additional supplementation. The importance of prevention: With any health problem it is much more prudent and efficient to prevent disease by maintaining a high level of immune function. Research has shown that low NK cell activity is present nearly all illness. A daily dietary regimen that includes dialyzable bovine colostrum/whey extract has been shown to significantly help maintain high NK cell activity and thereby dramatically increase the ability of the immune system to maintain a healthy condition. Conclusions: This Study Group demonstrates that stimulation of NK activity paralleled restored resistance to illness and recovery from illness. NK cell activity is correlated with disease status in those patients with hematologic malignancy such as leukemia and lymphomas as well. In some studies, on patients with leukemia, a sudden and maintained decrease in NK cell activity was reported nearly always to proceed relapse even if the patient had been in complete remission for some time. This also correlated with a general drop in the percentage of lymphocytes as measured in a standard blood test. NK cell function is a well-regulated activity subject to both inhibitory and excitatory control. References 1) “Purification of transfer factors”, Rosso, S.J. et al, Mol. Immunol. 1992, Feb; 29(2): 167-82 2) Transfer factor is effective across different mammalian species. “Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate” by Dr. Qitly et al, Acta Virol 1992, May; 36(3): 231-8 3) Transfer factor is just as effective when taken orally as by injection. “Murine transfer factors: dose-response relationships and routes of administration” Kirk Patrick, C.H., et al, Cell Immunol, 1995, Sep; 164(2): 203-6 4) “Transfer factor presents relapse in herpes keratitis patients; a pilot study” Pizza, G. et al, Biotherapy 1994; 8(1): 63-8 5) “Adjuvant treatment using transfer factor for bronchogenic carcinoma: long-term follow-up”, Whyte, R.I. et al, Arr Thoracic Surgery, 1992, Mar; 53(3):391-6 6) “Immunotherapy with transfer factor of recurrent herpes simplex type I”, Estranda-Parra, S. et al, Arch Med Res, 1995;26 7) ”Effect of Brucella abortus transfer factor in preventing murine brucellosis”, Stevens, M.G. et al, Immunol Med Microbiol, 1995, Jul; 11(4): 279-84 8) “Transfer factor in malignancy”, Pizza, G. et al, Prog Drug Res 1994; 42:401-21 9) “Specific transfer factor with activity against Epstein-Barr virus reduces late relapse in endemic Burkitt’s lymphoma”, Neequaye, J. et al, Anticancer Research 1990 Sept-Oct; 10 (5A): 1183-7 10) “A controlled trial of bovine dialyzable lukocyte extract (transfer factor) for cryptosporidiosis in patients with AIDS” McMeeking, A. et al, J. Infect Dis,1990 Jan; 161(1): 108-12 11) Clark D, Wyatt K: Colostrum, Life’s First Food. Salt Lake City: CNR Publications, 1996. 12) Lange S: Immune mechanisms of cardiac disease. New England Journal Of Medicine 330(7): 1129, April 21, 1994. 13) Kohl S, et al: Human colostral cytotoxicity: antibody-dependent cellular cytotoxicity against herpes simplex infected cells mediated by colostral cells. Journal of Clinical Laboratory Immunology 1:221-224. 14) Acosta-Altamirano G, et al: Anti-amoebic properties of human colostrum. Adv Exp Med Biol 216B: 1347-1352, 1987. 15) Boesman-Finkelstein M., et al: Passive oral immunization of children. The Lancet. 49:1336, 1989. 16) Haynes BF, Fauci AS: Introduction to clinical immunology. Part II, section 2. in: Harrison’s Principles of Internal Medicine, Eleventh Edition. Braunwald E (eds), et al. New York: McGraw Hill Book Co, Janusz M, et al: Immunoregulatory properties of synthetic peptides: fragments of a proline-rich polypeptide from bovine colostrum. Molecular Immunology 24(10): 1029-1031, 1987. 17) Kim K, et al: In vitro and in vivo neutralizing activity of human colostrum and milk against purified toxins A and B of Clostridium difficile. T Infect Dis 150:57-61, 1985. 18) Ogra P, et al: Colostrum derived immunity and maternal neonatal interaction. Annals NY Acad Sci 409:82-92, 1983. 19) Palmer EL, et al: Antiviral activity of colostrum and serum immuno-globulins A and G. J Med Virol 5:123-129, 1980. 20) Sabirl, AB: Anti-poliomyelitic substance in milk from human beings and certain cows. T Dis Children 80:866-870, 1950. 21) Spik, G., et al., Bacteriostasis of a milk-sensitive strain of E. coli by immuno-globulins and iron-binding proteins associated with colostrum. Immunology 35:663-670, 1981. 22) Stephan W, et al: Antibodies from colostrum in oral immunotherapy. J Clin Chem Clin Biochem 28:19-23,1990. 23) Wada N, et al: Neutralizing activity against Clostridium difficile toxins in the supernatants of cultured colostral cells. Infect Immune 29:545-550,1980. 24) Ferrer-Argote VE; Romero-Cabello R; Hernandez-Mendoza L; Arista-Viveros A; and others Successful treatment of severe complicated measles with non-specific transfer factor. Department of Hematology, Hospital General de Mexico, DF, Mexico. In Vivo 1994 Jul-Aug; 8 (4): 555-7 25) Rebulla P; Tedesco F; Radillo O; Battaglioli M; and others. Inhibition of in vitro adherence of antibody-coated red cells to monocytes by the dialyzable leukocyte extract. Centro Trasfusionale e di Immunologia dei Trapianti, Ospedale Policlinico, Milan, Italy. Transfusion 1991 Mar-Apr; 31 (3): 218-21 26) Fazio M; Negri L; Calabrese F; Correggia F; and others A new method for the in vitro transfer of delayed hypersensitivity by dialysed transfer factor. J Nucl Med Allied Sci 1990 Oct-Dec; 34 (4 Suppl): 271-4 27) Fazio M; Calabrese F; Giacomasso S; Meina G; and other Transfer in vivo of tuberculin hypersensitivity by sensitized lymphocytes. Chair of Medical Oncology, University of Turin, Italy. Panminerva Med 1993 Sep; 35(3): 149-53 28) Mrazova A; Mraz J Transfer factor and its signification for practice. Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove 1993; 36(3): 117-37 29) Sumiyama K; Kobayashi M; Miyashiro E; Koike M Combination therapy with transfer factor and high dose stronger neo-minophagen C in chronic hepatitis B in children (HBe Ag positive). Department of Pediatrics, Wakayama Medical College, Japan. Acta Paediatr Jpn 1991 Jun; 33(3): 327-34 30) Snirc J; Mikula I; Pistl J The induction of specific protection against Actinobacillus pleuropneumoniae infection by specific DLE. Department of Microbiology and Immunology, University of Veterinary Medicine, Kosice, Slovakia.Acta Microbiol Hung 1993; 40(4): 325-33 31) Qi HY; Wan ZF; Su CZ Isolation and purification of HSV-1 specific transfer factor produced by HSV-1 immunized goat leukocyte dialysate. Department of Biochemistry, Fourth Military Medical University, Xian, P.R. China. Acta Virol 1992 May; 36(3): 231-8 32) Fernandez O; Diaz N; Morales E; Toledo J; and others Effect of transfer factor on myelosuppression and related morbidity induced by chemotherapy in acute leukaemias. Hospital Universitario Dr. Carlos J. Finlay, Marianao, Cuba. Br J Haematol 1993 Jul; 84(3): 423-7 33) Kirkpatrick CH Structural nature and functions of transfer factors. Conrad D. Stephenson Laboratory for Research in Immunology, National Jewish Center for Immunology and Respiratory Medicine, Denver, Colorado 80206. REVIEW ARTICLE: 26 REFS. Ann N Y Acad Sci 1993 Jun 23; 685: 362-8 Study Group Profile Background: NK cell activity (Lytic Units) in a healthy population NK cell activity (Lytic Units) in the U.S. population 150-225 20-50 Study Group size and gender: 107 participants 59 females 48 males Average age Youngest Oldest 53 years 17 years 83 years Presenting disease as a percentage of the Total Study Group: Cancer 50% Chronic Fatigue Syndrome 30% Others 20% Including Lupus, Allergies, Fibromyalgia, Blood Disorders, Chronic Infections, Recurrent Infections, Autoimmune Diseases, and Cervical Dysplasia/Metaplasia. All Study Group participants recorded significantly higher NK cell activity. Average initial NK cell activity 18 Lytic Units. Average final NK cell activity 246 Lytic Units. Average monthly increase in NK cell activity by participants Average percentage of improvement 28.25 Lytic Units. 1,267%. Treatment period: Total participant treatment time 1,422 months. Average participant treatment time 13.2 months. Number of capsules used by participants 2-8 per day.